Inhibiting 15-PGDH blocks blood–brain barrier deterioration and protects mice from Alzheimer’s disease and traumatic brain injury

Proceedings of the National Academy of Sciences, Volume 122, Issue 21, May 2025.
SignificanceKoh et al. show that 15-hydroxyprostaglandin dehydrogenase (15-PGDH) is pathologically elevated in human and mouse Alzheimer’s disease (AD), traumatic brain injury (TBI), and aging, with 15-PGDH localized to myeloid cells of the blood–brain …
Read More

Related posts

ZRP Recruitment 2026: Full List Of Requirements, Vacancies, Application Procedures And Deadline Explained

Applications now open for Esports World Cup co-streaming program

Durham And Japan: Driving Forward Global Solutions | Mirage News